RZH
Relyea Zuckerberg Hanson’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.59M | Buy |
24,705
+391
| +2% | +$72.6K | 0.54% | 37 |
|
|
2025
Q1 | $5.09M | Buy |
24,314
+224
| +0.9% | +$46.9K | 0.69% | 31 |
|
|
2024
Q4 | $4.28M | Buy |
24,090
+13,902
| +136% | +$2.47M | 0.58% | 34 |
|
|
2024
Q3 | $2.01M | Buy |
10,188
+217
| +2% | +$42.9K | 0.31% | 49 |
|
|
2024
Q2 | $1.71M | Buy |
9,971
+135
| +1% | +$23.2K | 0.29% | 51 |
|
|
2024
Q1 | $1.79M | Buy |
9,836
+534
| +6% | +$97.2K | 0.31% | 46 |
|
|
2023
Q4 | $1.44M | Buy |
9,302
+248
| +3% | +$38.4K | 0.28% | 53 |
|
|
2023
Q3 | $1.35M | Buy |
9,054
+704
| +8% | +$105K | 0.31% | 50 |
|
|
2023
Q2 | $1.12M | Buy |
8,350
+495
| +6% | +$66.7K | 0.25% | 59 |
|
|
2023
Q1 | $1.25M | Buy |
7,855
+969
| +14% | +$154K | 0.31% | 52 |
|
|
2022
Q4 | $1.11M | Buy |
6,886
+947
| +16% | +$153K | 0.32% | 50 |
|
|
2022
Q3 | $797K | Buy |
5,939
+259
| +5% | +$34.8K | 0.29% | 51 |
|
|
2022
Q2 | $870K | Buy |
5,680
+46
| +0.8% | +$7.05K | 0.32% | 50 |
|
|
2022
Q1 | $896K | Sell |
5,634
-119
| -2% | -$18.9K | 0.29% | 57 |
|
|
2021
Q4 | $759K | Buy |
5,753
+566
| +11% | +$74.7K | 0.28% | 64 |
|
|
2021
Q3 | $560K | Buy |
5,187
+144
| +3% | +$15.5K | 0.22% | 73 |
|
|
2021
Q2 | $568K | Buy |
5,043
+122
| +2% | +$13.7K | 0.23% | 65 |
|
|
2021
Q1 | $548K | Buy |
4,921
+203
| +4% | +$22.6K | 0.24% | 64 |
|
|
2020
Q4 | $506K | Sell |
4,718
-10
| -0.2% | -$1.07K | 0.27% | 64 |
|
|
2020
Q3 | $403K | Sell |
4,728
-40
| -0.8% | -$3.41K | 0.26% | 70 |
|
|
2020
Q2 | $468K | Hold |
4,768
| – | – | 0.37% | 60 |
|
|
2020
Q1 | $363K | Hold |
4,768
| – | – | 0.4% | 60 |
|
|
2019
Q4 | $422K | Buy |
+4,768
| New | +$422K | 0.41% | 56 |
|